Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori : A Randomized Trial

Jyh-Ming Liou, Chi-Yang Chang, Mei-Jyh Chen, Chieh-Chang Chen, Yu-Jen Fang, Ji-Yuh Lee, Jeng-Yih Wu, Jiing-Chyuan Luo, Tai-Cherng Liou, Wen-Hsiung Chang, Cheng-Hao Tseng, Chun-Ying Wu, Tsung-Hua Yang, Chun-Chao Chang, Hsiu‐Po Wang, Bor-Shyang Sheu, Jaw-Town Lin, Ming-Jong Bair, Ming-Shiang Wu, Taiwan Gastrointestinal Disease and Helicobacter Consortium, None, The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0124199

J. Molina-Infante, J. P. Gisbert, Clarithromycin or levofloxacin in the sequential therapy for H. pylori eradication? authors’ reply Alimentary Pharmacology & Therapeutics. ,vol. 31, pp. 1249- 1250 ,(2010) , 10.1111/J.1365-2036.2010.04297.X

Juan Qian, Feng Ye, Jun Zhang, Yan-Mei Yang, Hui-Ming Tu, Qi Jiang, Li Shang, Xiao-Lin Pan, Rui-Hua Shi, Guo-Xin Zhang, Levofloxacin-containing Triple and Sequential Therapy or Standard Sequential Therapy as the First Line Treatment for Helicobacter pylori Eradication in China Helicobacter. ,vol. 17, pp. 478- 485 ,(2012) , 10.1111/J.1523-5378.2012.00993.X

Constanza M Camargo, Apolinaria García, Arnoldo Riquelme, William Otero, Claudia A Camargo, Tomas Hernandez-García, Roberto Candia, Michael G Bruce, Charles S Rabkin, None, The Problem of Helicobacter pylori Resistance to Antibiotics: A Systematic Review in Latin America The American Journal of Gastroenterology. ,vol. 109, pp. 485- 495 ,(2014) , 10.1038/AJG.2014.24

Javier P. Gisbert, Ángeles Pérez-Aisa, Fernando Bermejo, Manuel Castro-Fernández, Pedro Almela, Jesús Barrio, Ángel Cosme, Inés Modolell, Felipe Bory, Miguel Fernández-Bermejo, Luis Rodrigo, Jesús Ortuño, Pilar Sánchez-Pobre, Sam Khorrami, Alejandro Franco, Albert Tomas, Iván Guerra, Eloisa Lamas, Julio Ponce, Xavier Calvet, Second-line Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection Journal of Clinical Gastroenterology. ,vol. 47, pp. 130- 135 ,(2013) , 10.1097/MCG.0B013E318254EBDD

David Y. Graham, Yi–Chia Lee, Ming–Shiang Wu, Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. Clinical Gastroenterology and Hepatology. ,vol. 12, pp. 177- 186 ,(2014) , 10.1016/J.CGH.2013.05.028

David Y. Graham, Hong Lu, Yoshio Yamaoka, A report card to grade Helicobacter pylori therapy. Helicobacter. ,vol. 12, pp. 275- 278 ,(2007) , 10.1111/J.1523-5378.2007.00518.X

Kamil Özdil, Turan Çalhan, Abdurrahman Şahin, Ebubekir Şenateş, Resul Kahraman, Bilgehan Yüzbaşıoğlu, Hakan Demirdağ, Hüseyin Demirsoy, H. Mehmet Sökmen, Levofloxacin based sequential and triple therapy compared with standard plus probiotic combination for Helicobacter pylori eradication. Hepato-gastroenterology. ,vol. 58, pp. 1148- 1152 ,(2011) , 10.5754/HGE11075

David Y. Graham, Helicobacter pylori Eradication Therapy Research: Ethical Issues and Description of Results Clinical Gastroenterology and Hepatology. ,vol. 8, pp. 1032- 1036 ,(2010) , 10.1016/J.CGH.2010.07.002

J. MOLINA-INFANTE, B. PEREZ-GALLARDO, M. FERNANDEZ-BERMEJO, M. HERNANDEZ-ALONSO, G. VINAGRE, C. DUEÑAS, J. M. MATEOS-RODRIGUEZ, G. GONZALEZ-GARCIA, E. G. ABADIA, J. P. GISBERT, Clinical trial: clarithromycin vs. levofloxacin in first‐line triple and sequential regimens for Helicobacter pylori eradication Alimentary Pharmacology & Therapeutics. ,vol. 31, pp. 1077- 1084 ,(2010) , 10.1111/J.1365-2036.2010.04274.X